Inventor · disambiguated record
Jonathan Langdown
Also filed as: LANGDOWN JONATHAN
8 granted patents·2 pending applications·37 citations·filing 2012–2021
85Inventor score
Files withJANSSEN PHARMACEUTICALS INC10
Top patents by PatentIndex Score
10 records- 0195US9605082B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·11 cites·24 claims
- 0292US9518128B2Thrombin-binding antibody moleculesJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Dec 13, 2016·10 cites·27 claims
- 0388US9988461B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 5, 2018·3 cites·31 claims
- 0488US9518129B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2012·Granted Dec 13, 2016·9 cites·25 claims
- 0584US9988463B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·3 cites·21 claims
- 0681US10370454B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·1 cites·5 claims
- 0774US2021371543A1Thrombin-Binding Antibody Molecules And Uses ThereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0871US11155637B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Oct 26, 2021·0 cites·13 claims
- 0965US10287363B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·0 cites·7 claims
- 1064US2019276558A1Thrombin-Binding Antibody Molecules And Uses ThereofJANSSEN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Langdown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →